Clinical Trials Browser

Phase 1/2 × Carcinoma, Transitional Cell × LHRH, lysine(6)-doxorubicin × Clear all

NCT01234519 2018-03-15

A Phase I/II Trial of AEZS-108 in Urothelial Cancer Patients Who Failed Platinum-chemotherapy

Phase 1/2 Terminated

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Ureteral Neoplasms